COMMUNIQUÉS West-GlobeNewswire

Relay Therapeutics Announces Pricing of Public Offering of Common Stock
21/05/2026
CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage, small molecule precision medicine company developing potentially life-changing therapies for patients living [...]
NeuroZen Under Investigation - Critical Assessment Reveals Shocking Consumer Report Details Disclosed
21/05/2026
NeuroZen Scam or Legit, Consumer Complaints, Side Effects, Tinnitus Ear Health Ingredients, Does It Work, Pricing, and 60-Day Guarantee Explained Largo, FL, May 20, 2026 (GLOBE NEWSWIRE) -- These statements have not [...]
Sifts Microplastic Binding Supplement Claims Evaluated: The Chitosan Fiber Formula for Daily Microplastic Particle Exposure Support
21/05/2026
Chitosan's Electrostatic Fiber Mechanism, Ingredient-Level Research, and How the Formula Is Designed to Support Digestive Tract Particle Exposure Routines Daily Emmett, ID, May 20, 2026 (GLOBE NEWSWIRE) -- Disclaimer: [...]
BioAdaptives Launches MyndSystem™ Website — The First Supplement Platform Designed to Support Both Daytime Cognitive Performance and Overnight Brain Recovery
20/05/2026
Perform. Repair. Repeat. — A stimulant-free, dual-phase platform built on the principle that cognitive excellence depends as much on what the brain does overnight as on what it achieves during the day. LAS VEGAS, May 20 [...]
L’Assemblée Générale Mixte de Cellectis se tiendra le le 25 juin 2026
20/05/2026
NEW YORK, 20 mai 2026 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS), société de biotechnologie de stade clinique qui utilise sa technologie pionnière d’édition du génome pour développer des [...]
Cytokinetics to Hold Annual Meeting of Stockholders
20/05/2026
SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that its Annual Meeting of Stockholders will be held on Wednesday, May 27, 2026 at 10:00 AM Pacific [...]
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum
20/05/2026
Nyxoah Welcomes the Flemish Investors Federation (VFB) at LégiaPark following Q1 2026 Results and U.S. Commercial Momentum Mont-Saint-Guibert, Belgium – May 20, 2026, 10:05 pm CET / 4:05 pm ET – Nyxoah SA (Euronext [...]
Nanobiotix Announces Launch of Global Follow-On Offering
21/05/2026
PARIS and CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based [...]
Nanobiotix annonce le lancement d’une offre globale
21/05/2026
Paris, France ; Cambridge, Massachusetts (USA), 20 mai 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – « Nanobiotix » ou la « Société »), une société de biotechnologie au stade clinique et en phase [...]
Cellectis’ Annual Shareholders General Meeting to be Held on June 25, 2026
20/05/2026
NEW YORK, May 20, 2026 (GLOBE NEWSWIRE) -- Cellectis (the “Company”) (Euronext Growth: ALCLS- NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell [...]
Vivos Therapeutics Reports First Quarter 2026 Financial Results and Provides Operational Update
20/05/2026
Year-over-year revenue increased 70%, reflecting contribution from Vivos’ acquisition of The Sleep Center of Nevada Management to Host Conference Call today at 5:00 pm ET LITTLETON, Colo., May 20, 2026 (GLOBE NEWSWIRE [...]
Strongest Phentermine Alternatives 2026: What OTC Options Are Commonly Compared to Phentermine? PhenQ Formulation Assessment Using the SCALE-9 Evaluation Model
20/05/2026
PhenQ Editorial Report: OTC appetite suppressants, natural weight loss pills, prescription vs OTC standards, and a 9-point consumer verification framework for evaluating real-world effectiveness. New York City, NY, May [...]
Ceribell to Participate in the William Blair 46th Annual Growth Stock Conference
20/05/2026
SUNNYVALE, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological [...]
Nyxoah Accueille la Fédération Flamande des Investisseurs (VFB) à LégiaPark à la Suite des Résultats du Premier Trimestre 2026 et de la Dynamique Commerciale aux États-Unis
20/05/2026
Nyxoah Accueille la Fédération Flamande des Investisseurs (VFB) à LégiaPark à la Suite des Résultats du Premier Trimestre 2026 et de la Dynamique Commerciale aux États-Unis Mont-Saint-Guibert, Belgique – 20 mai 2026, [...]
Nanobiotix Announces Launch of Global Follow-On Offering
21/05/2026
PARIS and CAMBRIDGE, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- NANOBIOTIX (Euronext: NANO – NASDAQ: NBTX – “ Nanobiotix ” or the “ Company ”), a late-clinical stage biotechnology company pioneering physics-based [...]
Dentsply Sirona to Participate in the 2026 Stifel Jaws & Paws Conference
20/05/2026
CHARLOTTE, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will participate in the 2026 Stifel Jaws & Paws Conference [...]
Corvus Pharmaceuticals to Present at the 2026 Jefferies Global Healthcare Conference and Goldman Sachs 47th Annual Global Healthcare Conference
20/05/2026
SOUTH SAN FRANCISCO, Calif., May 20, 2026 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct one [...]
Dyne Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
20/05/2026
WALTHAM, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc . (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular [...]
Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities
20/05/2026
MIAMI, May 20, 2026 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company developing cellular therapy for life-threatening, rare pediatric and chronic aging-related conditions, today [...]

Pages